U.S. Reaches $2.1 Billion Deal With Sanofi and GlaxoSmithKline For Coronavirus Vaccine

Director of the National Institutes of Health, Dr. Francis Collins, holds a model of the coronavirus as he testifies at a US Senate hearing to review Operation Warp Speed: the researching, manufacturing, and distributing of a safe and effective coronavirus vaccine, in Washington, DC, on July 2, 2020.

Federal government makes sixth and largest deal for coronavirus vaccine candidate as part of Operation Warp Speed.

(Image credit: SAUL LOEB/POOL/AFP via Getty Images)

Read the full post on Health Care : NPR

Sydney Lupkin